DPCM CAPITAL INC - CLASS A (XPOA) Stock Fundamental Analysis

NYSE:XPOA • US23344P1012

8.66 USD
-0.02 (-0.23%)
At close: Aug 5, 2022
12.55 USD
+3.89 (+44.92%)
After Hours: 8/5/2022, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, XPOA scores 1 out of 10 in our fundamental rating. XPOA was compared to 0 industry peers in the Unkown industry. The financial health of XPOA is average, but there are quite some concerns on its profitability. XPOA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year XPOA was profitable.
XPOA Yearly Net Income VS EBIT VS OCF VS FCFXPOA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 1.81%
ROE 1.99%
ROIC -1.39%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XPOA Yearly ROA, ROE, ROICXPOA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 2 4 6 8

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for XPOA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XPOA Yearly Profit, Operating, Gross MarginsXPOA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • XPOA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • XPOA has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for XPOA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
XPOA Yearly Shares OutstandingXPOA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M
XPOA Yearly Total Debt VS Total AssetsXPOA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M

2.2 Solvency

  • XPOA has an Altman-Z score of 7.18. This indicates that XPOA is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for XPOA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.18
ROIC/WACC-0.16
WACC8.71%
XPOA Yearly LT Debt VS Equity VS FCFXPOA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 0.03 indicates that XPOA may have some problems paying its short term obligations.
  • A Quick Ratio of 0.03 indicates that XPOA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
XPOA Yearly Current Assets VS Current LiabilitesXPOA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for XPOA have decreased strongly by -64.11% in the last year.
EPS 1Y (TTM)-64.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • XPOA is valuated quite expensively with a Price/Earnings ratio of 61.86.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, XPOA is valued quite expensively.
Industry RankSector Rank
PE 61.86
Fwd PE N/A
XPOA Price Earnings VS Forward Price EarningsXPOA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPOA Per share dataXPOA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for XPOA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DPCM CAPITAL INC - CLASS A

NYSE:XPOA (8/5/2022, 8:04:00 PM)

After market: 12.55 +3.89 (+44.92%)

8.66

-0.02 (-0.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.8%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap324.75M
Revenue(TTM)N/A
Net Income(TTM)5.42M
Analysts82.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 61.86
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.14
EY1.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.28
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.81%
ROE 1.99%
ROCE N/A
ROIC -1.39%
ROICexc N/A
ROICexgc -1.39%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 7.18
F-Score3
WACC8.71%
ROIC/WACC-0.16
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

DPCM CAPITAL INC - CLASS A / XPOA FAQ

Can you provide the ChartMill fundamental rating for DPCM CAPITAL INC - CLASS A?

ChartMill assigns a fundamental rating of 1 / 10 to XPOA.


What is the valuation status of DPCM CAPITAL INC - CLASS A (XPOA) stock?

ChartMill assigns a valuation rating of 1 / 10 to DPCM CAPITAL INC - CLASS A (XPOA). This can be considered as Overvalued.


How profitable is DPCM CAPITAL INC - CLASS A (XPOA) stock?

DPCM CAPITAL INC - CLASS A (XPOA) has a profitability rating of 1 / 10.


What is the financial health of DPCM CAPITAL INC - CLASS A (XPOA) stock?

The financial health rating of DPCM CAPITAL INC - CLASS A (XPOA) is 2 / 10.